Search results
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...
Morningstar· 5 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ventyx Biosciences, Inc ...
Rakuten Securities Inc. Makes New Investment in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoRakuten Securities Inc. bought a new stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 15 hours agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday ...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
AOL· 15 hours agoThe Radiation Exposure Compensation Act has been a lifeline for some people and families exposed to toxins linked to decades-old nuclear weapons tests, but advocates say more people deserve ...
TD Cowen Lowers Amgen (NASDAQ:AMGN) Price Target to $360.00
ETF DAILY NEWS· 7 days agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target dropped by TD Cowen from $370.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a ...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 13 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...
Morningstar· 3 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming match to reference medicine in terms of safety
Sigma Planning Corp Has $1.85 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 3 days agoSigma Planning Corp decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 65.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...
Galapagos (NASDAQ:GLPG) Receives “Equal Weight” Rating from Morgan Stanley
ETF DAILY NEWS· 2 days agoGalapagos (NASDAQ:GLPG – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Morgan Stanley in a research report issued to clients and investors ...
UCB SA (OTCMKTS:UCBJY) Declares Dividend of $0.46
ETF DAILY NEWS· 4 days agoUCB SA (OTCMKTS:UCBJY – Get Free Report) declared a dividend on Friday, April 19th, investing.com reports. Stockholders of record on Monday, April 29th will be given a dividend of 0.4574 per ...